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COVID-19 vaccine1
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Once a safe COVID-19 vaccine will become available, there will not be 
enough supply of it to vaccinate the entire population. Policy makers 
at national and international level are currently developing vaccine 
prioritization strategies. However, it is important that these strategies 
have sufficient levels of public support. We conducted a ranking exercise 
and a discrete choice experiment on a representative sample of 2,000 
Belgians in order to elicit their preferences regarding how to distribute 
the COVID-19 vaccine across the population. We identified that three 
sub-groups had similarly high levels of support for access priority: the 
chronically ill, essential professions, and individuals likely to spread 
the virus the most. We identified two clusters of respondents. While both 
wanted to vaccinate essential professions, cluster one (N=1058) primarily 
wanted to target virus spreaders whereas cluster two (N=886) wanted to 
prioritize the chronically ill. Prioritizing those over 60 years of age was 
remarkably unpopular. Other strategies such as allocating the vaccine 
using a ‘lottery’, ‘first-come, first-served’ approach or willingness-to-pay 
received little support. Public opinion is a key variable for a successful 
engaged COVID-19 vaccination policy. A strategy simultaneously 
prioritizing medical risk groups, essential professions and spreaders 
seems to be most in line with societal preferences. When asked to choose, 
people agree to vaccinate essential professions but disagree whether to 
prioritise people with high-medical risk or virus spreaders.
1 This study did not fall under the Belgian law on experiments as anonymized data collected by a third party 
were analysed and the Social and Medical Ethics Committee (SMEC) of KU Leuven decided that no approval 
was needed.
2 Professor of Health Economics, KU Leuven.
3 Professor of Health Economics, UCLouvain.
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1. Introduction 
After months of a global public health crisis, vaccines that are safe and effective in providing protection 
against the SARS-CoV-2 virus are expected to arrive (Mallapaty and Ledford 2020, Bloom, Nowak, 
and Orenstein 2020). Once available, a new challenge will emerge: their initial supply will be limited 
due to various production, logistic and regulatory constraints (Usher 2020, Khamsi 2020, Phelan et al. 
2020). In the first stages, it will be inevitable to make tough choices regarding how to distribute the 
vaccine over the population and it is expected that not all who could benefit from it will be able to be 
vaccinated (Subbaraman 2020, Schmidt 2020, Schmidt et al. 2020, Emanuel, Persad, Upshur, et al. 2020, 
Roope et al. 2020). The decision who should get vaccinated first needs to be prepared well in advance, 
in order to make sure that rationing of a life-saving product goes as fairly and smoothly as possible. 
Experts organisations such as the World Health Organisation (WHO) Strategic Advisory Group of 
Experts (SAGE) on Immunisation, the National Academies of Sciences, Engineering, and Medicine 
(NASEM), the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on 
Immunization Practices (ACIP) and more recently the European Commission (EC), have already issued 
guidelines regarding COVID-19 vaccine allocation and prioritisation strategies (Gayle et al. 2020, 
European Commission 2020, World Health Organization 2020). They have all identified subgroups of 
the population that should be prioritised for vaccines while manufacturers scale up production. The 
priority list includes the front-line health care workers, the highest risk categories - those above 60 years 
old or with coexisting conditions, people with an essential work, people who live in crowded settings 
and in higher risk environments. While the WHO and EC guidelines explicitly have stated that the 
identified groups are not ranked in order of prioritisation, NASEM has suggested a phased vaccines 
allocation where priority is guided by risk-based criteria. 
A key difficulty in finding a fair allocation of the COVID-19 vaccine will be to reconcile at least three 
objectives: to protect the medically worst-off, to protect public health, and to protect the economy and 
society functioning (Emanuel, Persad, Upshur, et al. 2020, Roope et al. 2020, Persad, Peek, and Emanuel 
2020, Liu, Salwi, and Drolet 2020). Each of these objectives point at different target groups of the 
population to prioritise when distributing the vaccines. For example, one could prioritize those at most 
risk of developing severe forms of COVID-19: those with comorbidities and weak immune systems in 
which a COVID-19 infection is most likely to be fatal, and older people with higher mortality odds 
(Clark et al. 2020). Whereas this strategy will perform best in reducing the short-term disease burden, 
vaccinating medically vulnerable groups does not necessarily do best in containing virus transmission, 
especially if vulnerable groups are already self-protecting and avoiding contacts. From a public health 
perspective, vaccination of the individuals that are most important in the transmission of the virus within 
society would be most effective in controlling COVID-19 contagion and could indirectly translate into 
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professions could be vaccinated first in order to minimize the social impact of the virus. In the first 
place, this would apply to healthcare workers (The Lancet 2020), whose protection is essential to avoid 
implosion of the health system but, by extension, other professions essential to society’s normal 
functioning could be targeted for vaccination. Finally, in order to mitigate further damages to already 
weakened economies, it might be a priority to vaccinate first the people who are most important to the 
economy, especially those who would cost more to society if they cannot keep working. Beyond specific 
population sub-groups, other strategies that have been suggested in the allocation of scarce medical 
resources, could be considered (Persad, Wertheimer, and Emanuel 2009, Emanuel, Persad, Kern, et al. 
2020, Persad, Peek, and Emanuel 2020). One could give everyone an equal chance to get a vaccine using 
for instance a lottery. One could also distribute the vaccine on a ‘first-come, first-served’ basis as it is 
sometimes done in other policy domains such as allocation of social housing. Eventually, access to a 
vaccine could be granted using people’s willingness-to-pay as it is done in a market system where the 
amount people are willing to pay would reflect the personal value they attribute to being vaccinated.  
All these alternative strategies have their own rationale to allocate the limited supply of COVID-19 
vaccines. It is far from obvious which specific mechanism is deemed most appropriate and most 
supported. Given the major collective dimension of the current crisis, the expected value of a vaccine 
and the turmoil that scarcity of it might instigate, it is important to understand which vaccines allocation 
mechanism seems the most acceptable to the public. Furthermore, as has already been evidenced with 
other measures (e.g physical distance, mouth masks, etc.) public support plays a crucial role in making 
pandemic countermeasures effective. 
In this article, we present the results of a study carried out on a representative sample of the general 
population in Belgium. We asked members of the public first to rank different specific population groups 
by order of priority to access COVID-19 vaccines and then to state their preferences over multiple pairs 
of hypothetical individuals for priority allocation. 
2. Methods 
2.1. Sample and survey 
We used a nationally representative panel of the market research agency SSI to complete a survey in 
between 6 and 16 October 2020. From a panel of 5,500 selected members that mirror the Belgian 
population as well as possible1, a sample of N=2,060 was drawn randomly, fulfilling pre-determined 
Belgium quota for age, gender, level of education and province.  
 
1 The research company evaluates it continuously, eliminates low-quality responders systematically and participation is 
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The survey first asked for a range of respondent sociodemographic characteristics along with their 
financial situation, general self-assessed health, attitude towards vaccination and toward the 
government’s dealing with the corona crisis, whether they had had COVID-19, whether someone they 
knew had it, was hospitalized because of it and had died because of it. Respondents were also asked 
whether their profession was among the ‘essential professions’ (i.e. those that were obliged to keep 
working during the first ‘lockdown’ in March/April 2020) and whether they considered themselves to 
be part of a risk group for COVID-19 and if so, which group they belonged to (old age, chronic illness, 
obesity, or other). The questionnaire was then followed with an explanation of the background to the 
study where we explicitly asked the respondents to think about what they considered the fairest to society 
when allocating the limited supply of COVID-19 vaccines, and not to choose simply what would be the 
most to their own advantage. After the ranking exercise and the choice experiment, respondents were 
asked about whom should decide who gets the COVID-19 vaccine first (government, scientists or the 
population), whether they would choose to be vaccinated themselves once a vaccine becomes available, 
and how easy they found answering the survey.  
2.2. Ranking exercise 
We presented the respondents with eight alternative strategies to distribute the COVID-19 vaccines 
summarized in Table 1. Each strategy was presented one after the other using successive new screens 
that respondents were only able to progress from every 10 seconds. The eight strategies were then 
summarised as a list in their short version (with the possibility to go back to the full explanation if 
needed) and respondents were asked to rank all of them from the ‘‘most appropriate’ to ‘least 
appropriate’ according to their opinion. They were told that the vaccine was equally safe and effective 
in all people.  




Full explanation as presented in the experiment 
Prioritizing 
chronically ill  
We could first give the vaccine to people who are medically most at risk of serious illness 
and death because they have another underlying condition: cancer patients, people with lung 
disease, heart disease, kidney disease, severe obesity, etc. By vaccinating them first, we 
would protect the people most vulnerable to the virus. 
Prioritizing the 
elderly 
We could first give the vaccine to people over 60 years old. We know that, on average, these 
people run a much higher risk of serious illness or death from a corona infection. By 
vaccinating them first, we would protect the people most vulnerable to the virus. 
Prioritizing 
spreaders 
We could first give the vaccine to the people who spread the virus the most because they have 
a lot of social contacts in their daily life (at work, at school, in their neighbourhood, in public 
transport, etc.). These people themselves are not at high risk of serious illness or death from 
COVID-19, but they can infect many others. By vaccinating them first, we would slow down 


























People who work will cause a greater economic cost when they become ill than those who do 
not work. By first vaccinating working people, we would ensure that the virus does as little 




Some professions are more "essential" to society than others. During the pandemic, health 
workers, hospital staff, police and garbage services had to continue working as usual, while 
others had to work from home or were temporarily unemployed. By prioritizing workers from 
these vital sectors, we would protect the normal functioning of society. 
Lottery We could distribute the available vaccines randomly among the population, for example 
through a lottery. Therefore, each individual would have the same chance to be vaccinated, 
regardless of their health risk or the social impact of an infection. 
First-come, 
first-served 
We could distribute the available vaccines to the population according to the principle "first-
come, first-served". People who present themselves the fastest for vaccination at the doctor, 
pharmacy or government would be given priority from the moment there is a vaccine. 
Market We could sell the available vaccines to the highest bidder. The people who want to pay the 
most money for a vaccine would be given priority. 
 
2.3. Discrete choice experiment 
We then subjected respondents to a discrete choice experiment (DCE). This is a widely used survey 
method to study individuals’ preferences.(Ryan, Gerard, and Amaya-Amaya 2008, Louviere, Hensher, 
and Swait 2000) Participants are presented with a series of choice sets, usually between two or more 
products or services that are described by the same attributes but they differ in their attribute levels. By 
observing a large number of choices, researchers can infer how attributes and levels implicitly determine 
the value of the competing options. Here, we presented respondents with a choice between two 
hypothetical people candidates for COVID-19 vaccination. Both candidates were described with 
identical attributes, but they differed in terms of the levels of these attributes so that we could infer how 
important these attributes were to the respondents when prioritizing one or the other candidate for 
vaccination. 
Attributes and levels. The DCE focused on five attributes of people: (1) their age, (2) whether they 
belonged to a medical risk group due to underlying illnesses, (3) their importance to the economy, (4) 
whether their profession was considered ‘essential’, and (5) whether they would spread the virus to 
many other people or not in case of infection (see Table 2). The remaining strategies from the ranking 
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§ Someone who has no underlying conditions 
§ Someone who has higher risk through chronic illness 
Age § Someone who is younger than 60 years  
§ Someone who is at least 60 
Virus  
spreader 
§ In case of infection, someone who is expected to contaminate 1 other person 
§ In case of infection, someone who is expected to contaminate 10 other persons 
Cost to  
society 
§ In case of infection, someone who is expected to cost society 0€ per day 
§ In case of infection, someone who is expected to cost society 100€ per day 
§ In case of infection, someone who is expected to cost society 1000€ per day 
Essential 
profession 
§ Someone who has a profession that is considered ‘essential’ 
§ Someone who has a profession that is considered not ‘essential’ 
 
 
Design. We designed the DCE using "partial profiles": we kept two levels constant between the two 
choice profiles whereas three levels varied.(Kessels, Jones, and Goos 2015, Kessels et al. 2011) This 
made the choice tasks easier to perform and therefore more reliable and valid for the analysis. The 
complete DCE survey consisted of 30 choice sets that we split into three different blocks of 10 choice 
sets. The three versions were then divided equally among respondents (one representative sample for 
each survey block). Within each survey, 10 choice sets were presented in a random order to respondents 
to counteract a possible "order effect". Before the DCE started, we presented the respondents with a 
mock choice set. This choice set was identical to their last ‘real’ choice set and allowed us to analyse 
the consistency in responses. Figure 1 presents an example of a choice set.  
The statistical design (the specific composition of the choice profiles) that we generated was "D-
optimal" within a Bayesian framework.(Kessels et al. 2011) This design makes it possible to examine 
the importance of the attributes and their levels with maximum precision. The complete design of the 
DCE is presented in Table A.2.  
We first tested various visualisations amongst a convenience sample (N=10) and then carried out a pilot 
study of the full survey in 174 respondents. After correcting for a few minor issues, we went ahead with 
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2.4. Statistical analysis 
We analysed the choice data by estimating a panel mixed logit (PML) model using the hierarchical 
Bayes technique in the JMP Pro 15 Choice platform (based on 10,000 iterations, with the last 5,000 used 
for estimation). This model assumes normally distributed utility parameters over the respondents to 
accommodate unobserved heterogeneity in the respondents’ preferences. The mean utility function is 
thereby the sum of the mean attribute effects. Using Ward’s hierarchical cluster analysis on the 
individual utility estimates, we identified important respondent segments that we characterized through 
bivariate chi-square analyses on the respondents’ covariates and multiple logistic regression with the 
cluster membership as response variable and the respondents’ covariates as explanatory variables. In all 
our analyses we used a significance threshold of five percent. 
3. Results 
On average the survey took respondents 21 minutes to complete (median 15.3). When asked how 
difficult completion of the survey was, only 21 respondents (1%) indicated it was ‘too difficult’ whereas 
1,154 (56%) said it was “easy” and 43% found it “difficult but doable”. None of the response 
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respondents (77%) gave the same answer twice to the repeated choice set, however differing answers 
do not point at invalid answers as the strength of preferences can be weak in this context. We did observe 
116 respondents (6%) that gave the same answer throughout the DCE (‘straightliners’). As this is 
unlikely, we decided to exclude these as a way of caution, leaving us with 1,944 respondents for the 
analysis.  
Thirty-nine percent considered themselves part of a COVID-19 risk group. A small minority (<20%) of 
the sample had experience with a COVID-19 infection, either in themselves or their proximity. A small 
majority (59%) was dissatisfied with the government’s approach to the crisis. A large majority of 
respondents (78%) thought that the vaccine allocation decision should ultimately be determined by 
scientists; 10% thought the government should decide and 12% thought that it should be the population 
only. When asked whether they would become vaccinated with a COVID-19 vaccine, 74% responded 
affirmatively (see Table A.1).  
3.1. Ranking exercise results 
The ranking exercise results are summarized in Figure 2. We use cumulative distribution functions to 
synthesize how each strategy was ordered by the respondents. The graphical representation shows that 
there was not one single strategy that dominated and was considered as absolute best by a large majority.  
Figure 2: Cumulative distribution functions of alternative COVID-19 vaccine allocation strategies 




The eight strategies are clearly divided into three groups: three dominant strategies, two strategies 
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essential workers, chronically ill and elderly were found to be the three most supported strategies. On 
the other hand, market, lottery or “first-come, first-served” strategies were clearly the least preferred 
strategies with at least 80% of the respondents ranking them at the bottom of the ranking. Finally, 
targeting spreaders or protecting the economy were strategies ranked in the middle. 
While the lottery strategy was very unpopular (79% ranked it in the top 3 of worst strategies), one in ten 
respondents thought that this was a very good strategy and ranked it as the most or second most 
appropriate strategy for allocating vaccines in the population. Analysing further this group of 
respondents, we found that the lottery strategy was more attractive to younger respondents (25-34), with 
a basic educational level, with regular financial problems, who think vaccination is useless and who 
doubt becoming vaccinated themselves with the COVID-19 vaccine, and who are dissatisfied with the 
government’s policy towards the corona crisis (all chi-square test p-values <0.001). They were also 
more likely to think that vaccine allocation should be driven by the preferences of the population instead 
by those of policy makers or scientists. 
3.2. DCE results 
In total, we analysed 19,440 choices between hypothetical individuals competing for vaccination. We 
first estimated model A (see Table 3 and Figure 3) that summarizes the choices made by the whole 
sample and that can reflect the preferences over the five attributes of the average respondent. This model 
showed that there was not one single attribute that dominated the other attributes and that gave a 
subgroup of the population lexical priority over others. Instead, we found that three attributes were of 
large importance: belonging to a medical risk group, having an ‘essential profession’ and being a 
relatively large spreader of the virus. Belonging to a medical risk group was found to be the most 
important one. While older people are also labelled as higher risk groups with COVID-19, being in an 
older age group was not found to be a strong predictor of priority to vaccine access by the public. 
Vaccinating first people who would be costly to the society if they have COVID-19 did not appear to 
matter either. 
When adding all possible first-order interaction effects between the five attributes into model A, we 
identified a few interactions that were of practical relevance. The combinations of being older than 60 
and having an essential profession, having a high cost to society and essential profession, or being part 
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Subject Std Dev Lower 
95% 
Upper 95% 
Model A (N=1944) 
Medical risk group      
  Yes 0.676** 0.024 0.446 0.632 0.724 
  No -0.676** 0.024 0.446 -0.724 -0.632 
Older than 60 
     
  Yes 0.093** 0.015 0.442 0.064 0.124 
  No -0.093** 0.015 0.442 -0.124 -0.064 
Virus spreader  
     
  10 other persons 0.660** 0.024 0.468 0.614 0.708 
  1 other person -0.660** 0.024 0.468 -0.708 -0.614 
Cost to society 
     
  0 €/day -0.123* 0.026 0.251 -0.173 -0.078 
  100 €/day -0.011* 0.022 0.146 -0.054 0.030 
  1000 €/day 0.134* 0.027 0.262 0.082 0.187 
Essential profession 
     
  Yes 0.567** 0.019 0.519 0.529 0.604 
  No -0.567** 0.019 0.519 -0.604 -0.529 
Model B (N=1058) 
Medical risk group  
     
  Yes 0.309** 0.023 0.072 0.265 0.352 
  No -0.309** 0.023 0.072 -0.352 -0.265 
Older than 60 
     
  Yes -0.202** 0.017 0.291 -0.236 -0.169 
  No 0.202** 0.017 0.291 0.169 0.236 
Virus spreader  
     
  10 other persons 0.911** 0.032 0.477 0.849 0.973 
  1 other person -0.911** 0.032 0.477 -0.973 -0.849 
Cost to society 
     
  0 €/day -0.334** 0.032 0.273 -0.400 -0.275 
  100 €/day 0.060** 0.029 0.224 0.002 0.114 
  1000 €/day 0.274** 0.030 0.298 0.213 0.334 
Essential profession 
     
  Yes 0.362** 0.020 0.381 0.323 0.402 
  No -0.362** 0.020 0.381 -0.402 -0.323 
Model C (N=886) 
Medical risk group  
     
  Yes 1.394** 0.060 0.547 1.276 1.521 
  No -1.394** 0.060 0.547 -1.521 -1.276 
Older than 60 
     
  Yes 0.504** 0.029 0.438 0.449 0.564 
  No -0.504** 0.029 0.438 -0.564 -0.449 
Virus spreader  
     
  10 other persons 0.480** 0.037 0.125 0.409 0.562 
  1 other person -0.480** 0.037 0.125 -0.562 -0.409 
Cost to society 
     
  0 €/day -0.050 0.033 0.130 -0.119 0.014 
  100 €/day 0.004 0.039 0.221 -0.071 0.072 
  1000 €/day 0.046 0.042 0.240 -0.039 0.129 
Essential profession 
     
  Yes 0.975** 0.046 0.737 0.886 1.071 
  No -0.975** 0.046 0.737 -1.071 -0.886 
** Significant at p<0.001, * Significant at p<0.05 
 
Since an overall model based on the average respondent can be misleading in case a population is 
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of respondents within the sample. The preferences of the first cluster (n=1,058, 54% of the sample) are 
summarized by model B. This cluster was in favour of prioritizing spreaders. The second cluster (n=886 
respondents, 46%) is summarized in model C. These respondents prioritized vaccinating medical risk 
groups. Both clusters valued essential professions as the second most important attribute. Interestingly 
however, whereas people aged 60 or more were prioritized in cluster 2, they were not prioritized in 
cluster 1. Cluster 1 also valued people who were economically important whereas this attribute was 
statistically insignificant in cluster 2. Figure 3 presents the main utility effects of all the models in 
predicting respondents’ choices.  
We analysed whether there were any of individual characteristics associated with membership to clusters 
1 or 2. There were no strong profiles emerging. However, compared to those from cluster 1, bivariate 
analyses showed that respondents belonging to cluster 2 (prioritizing risk groups) were more likely part 
of a medical risk group for COVID-19, more likely to be working, more convinced of the value of 
vaccines in general, more likely to become vaccinated with the COVID-19 vaccine, less likely to think 
that the COVID-19 vaccine allocation strategy needed to be made only by the population, more likely 
to think that the government should make these decisions, and less likely to be French-speaking (all chi-
square test p-values <0.001). When these six factors were analysed jointly in a multivariate regression, 
the effect of belonging to a risk group or general attitude to vaccination became insignificant whereas 
the other four characteristics remained. There was no relationship between being a member of cluster 1 
or 2 and respondents’ age, having an ‘essential’ profession, financial situation, level of education or 
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Figure 3: Estimated utilities of the full sample (N=1944 respondents), cluster 1 (N=1058 
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4. Discussion 
This study lays bare clear patterns in how the general public wants to allocate COVID-19 vaccines when 
available.  
First, there is little support for approaches that are more libertarian-inspired such as highest willingness-
to-pay or ‘first-come, first served’ strategies. A strict egalitarian approach like a lottery also receives 
little support. The most supported strategies are those where priority groups are explicitly defined at a 
policy level.  
Second, when deciding which individual characteristics ought to matter to policy makers when ranking 
priority groups, respondents have a clear preference not to prioritize older aged individuals, even though 
they belong to higher risk groups for COVID-19. This was true also for respondents from older age 
groups. This would support the fair innings argument according to which priority should be given to the 
young over the old and age is an accepted criterion for scarce health care resources allocation under the 
assumptions that every individual is entitled to live for a reasonable length of life.(Williams and Evans 
1997) The general public would not prioritise for vaccination those who are of particular economic 
importance such as those who work. Instead, they prioritized vulnerable people with medical conditions, 
people who are instrumentally important to public health by playing a role in wider virus transmission 
in the population or people who are more important to society functioning such as those with essential 
professions.  
Third, when trying to compare and rank within the three main target groups, the population was divided 
in two clusters. A share adhered to a ‘utilitarian’ strategy of maximizing societal health outcomes by 
allocating vaccines strategically towards virus spreaders (cluster one).(Savulescu, Persson, and 
Wilkinson 2020) These people also thought that vaccinating those with high economic cost to society 
was to some extent relevant. The other cluster adhered to a ‘prioritarian’ strategy that put those people 
who are at medical highest risk first (cluster two). Being a virus spreader or someone who could cost a 
lot to the economy was of little or no importance in this cluster. However, both groups considered 
essential professions a priority group but of secondary importance. Age was of minor importance in both 
groups but whereas being older than 60 would receive priority in the ‘prioritarian’ group, in the 
‘utilitarian’ group we observed the opposite. It was not the case that membership of these clusters 
coincided with the interests of the respondents. For instance, there was no relationship between priority 
choices and being young (respectively old) or with having an essential profession or not. Respondents 
who were not working (students, retired or unemployed people and homemakers) were more likely to 
be part of the ‘utilitarian’ cluster one. Those belonging to a risk group were more likely part of the 
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What is remarkable is that there were similarities but also discrepancies between the ranking exercise 
and the DCE. Whereas elderly vaccination was within the top three strategies in the ranking exercise 
(although the lowest ranked one), in the DCE this attribute was found of minor importance. In the same 
vein, vaccinating spreaders was only a second-rate strategy in the ranking exercise, however, when we 
assorted it with concrete figures so that an individual would spread infection to either one or ten other 
people, this attribute became very important in one of the two clusters.  
How relevant are these observed preferences for the current debate? In the first place, we request some 
caution that, our results are based on experiment that can only be seen as an approximation of how the 
public thinks about COVID-19 vaccines allocation. Although we did our best to keep the exercise 
simple, and we did as many validity checks as possible, we cannot know how people would have 
responded if they had to consider these choices in a discussion format or if more details had been 
provided (e.g. on the actual sizes of the different priority sub-groups within the society). More 
fundamentally, while there is almost a consensus on the priority candidates to the COVID-19 vaccines, 
ranking within those key groups is not straightforward and there is not a consensus of whom should be 
vaccinated first, second, and so on. The difficulty of defining a clear ranking among the identified 
priority groups has also been observed in the COVID-19 vaccination strategies put forward by the EC 
and WHO SAGE expert groups (World Health Organization 2020, European Commission 2020).  
Making social trade-offs between health, the economy and the health system is difficult and it is not 
clear what the exact value of the public opinion has in comparison to the more informed and deliberate 
judgment of experts and politicians. However, we believe that, in the light of the large collective 
dimension of the COVID-19 crisis, the preferences of the public opinion are an essential input value to 
the debate. It is the goal of this study to provide such an evidence base.   
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6. Appendix 
Table A.1: Sample characteristics 
 
Characteristics Responses item N % 
Respondents’ general background 
Gender Female 951 49% 
Male 993 51% 
Age 18-24 194 10% 
25-34 330 17% 
35-44 331 17% 
45-54 379 19% 
55-64 321 17% 
65-80 389 20% 
Language Dutch 1112 57% 
French 832 43% 
Province Vlaams-Brabant 191 10% 
Waals-Brabant 129 7% 
Brussels Capital 176 9% 
Antwerpen 288 15% 
Limburg 157 8% 
East Flanders 249 13% 
West Flanders 200 10% 
Hainaut 115 6% 
Liège 186 10% 
Luxembourg 102 5% 
Namur 151 8% 
Education None  7 0% 
Primary school 61 3% 
First degree secondary school 187 10% 
Second degree secondary school 247 13% 
Third degree secondary school 684 35% 
Higher education (non-university) 468 24% 
University or post-university 
education 
268 14% 
PhD 14 1% 
Other 8 0% 
Have children Yes 1213 62% 
No 731 38% 
Profession Working 915 47% 
Homemaker 80 4% 
Student 158 8% 
Unemployed 129 7% 
Disabled 127 7% 
Retired 472 24% 
Other  63 3% 
Difficulties with monthly expenses Never  802 41% 
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Once every three months  391 20% 
Every month  329 17% 
Self-assessed health Very good 248 14% 
Good 741 41% 
Rather good 602 34% 
Bad 167 9% 
Very bad 22 1% 
Don’t know/don't want to say 14 1% 
Respondents’ Covid-19 related background 
Self-reported membership of a COVID-19 risk 
group  
No 1183 61% 
Yes, elderly 366 19% 
Yes, chronically ill 400 21% 
Yes, severe obesity 124 6% 
Yes, other 68 3% 
Self-reported profession is labelled as 'essential'  Yes 367 19% 
No 1577 81% 
Has had a COVID-19 infection Yes, confirmed with a test 57 3% 
Probably, but not confirmed with a 
test 
160 8% 
No 1727 89% 
Know personally someone who has had COVID-19 Yes, confirmed with a test 293 15% 
Probably, but not confirmed with a 
test 
175 9% 
No 1476 76% 
Know personally someone who was hospitalized for 
COVID-19 
Yes 118 6% 
No 1826 94% 
Know personally someone who died of COVID-19 Yes 83 4% 
No 1861 96% 
Satisfaction with government’s approach of COVID-
19 pandemic  
Very satisfied 58 3% 
Rather satisfied 729 38% 
Rather dissatisfied 787 40% 
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Table A.2:  Complete design of the DCE 
 











profession 1 1 yes yes 1 other person 0 yes 
1 1 no no 1 other person 1000 yes 
1 2 no yes 10 other persons 100 no 
1 2 no yes 1 other person 1000 yes 
1 3 yes yes 1 other person 0 no 
1 3 no yes 10 other persons 1000 no 
1 4 no yes 1 other person 100 yes 
1 4 no no 10 other persons 100 no 
1 5 no no 1 other person 100 yes 
1 5 yes no 1 other person 1000 no 
1 6 no yes 1 other person 1000 yes 
1 6 yes yes 10 other persons 1000 no 
1 7 yes no 10 other persons 1000 no 
1 7 yes yes 10 other persons 0 yes 
1 8 yes yes 1 other person 100 yes 
1 8 yes no 10 other persons 0 yes 
1 9 no yes 1 other person 0 yes 
1 9 yes no 1 other person 0 no 
1 10 yes no 1 other person 100 no 
1 10 no yes 10 other persons 100 no 
2 11 yes yes 1 other person 100 no 
2 11 no no 1 other person 0 no 
2 12 yes no 1 other person 100 yes 
2 12 yes no 10 other persons 0 no 
2 13 yes no 1 other person 0 yes 
2 13 no no 10 other persons 100 yes 
2 14 no yes 1 other person 0 yes 
2 14 no no 10 other persons 0 no 
2 15 yes no 10 other persons 100 no 
2 15 no no 10 other persons 1000 yes 
2 16 yes yes 1 other person 0 yes 
2 16 no yes 10 other persons 0 no 
2 17 no yes 1 other person 0 no 
2 17 no no 1 other person 100 yes 
2 18 no no 1 other person 1000 no 
2 18 no yes 10 other persons 0 no 
2 19 no no 10 other persons 0 yes 
2 19 yes yes 10 other persons 0 no 
2 20 yes yes 1 other person 1000 no 
2 20 no no 10 other persons 1000 no 
3 21 no no 10 other persons 1000 no 
3 21 yes yes 10 other persons 100 no 
3 22 no yes 1 other person 1000 no 
3 22 no yes 10 other persons 0 yes 
3 23 no no 10 other persons 0 yes 
3 23 yes no 1 other person 1000 yes 
3 24 yes no 1 other person 1000 no 
3 24 yes yes 10 other persons 1000 yes 
3 25 yes yes 10 other persons 100 yes 
3 25 no yes 10 other persons 1000 no 
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3 26 no yes 10 other persons 100 yes 
3 27 no yes 1 other person 100 no 
3 27 no no 1 other person 0 yes 
3 28 yes yes 1 other person 1000 yes 
3 28 yes no 10 other persons 100 yes 
3 29 yes yes 1 other person 100 yes 
3 29 no no 1 other person 100 no 
3 30 yes no 1 other person 1000 yes 
3 30 no yes 10 other persons 1000 yes 
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